Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2004
11/03/2004EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004EP1472219A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
11/03/2004EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
11/03/2004EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004EP1472209A2 Lipoxin a4 analogs
11/03/2004EP1472021A2 Compositions including ammonia oxidizing bacteria and methods of using same
11/03/2004EP1471974A1 Tumor necrosis factor combined with interferon in demyelinating diseases
11/03/2004EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004EP1471931A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/03/2004EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004EP1471913A2 Treatment of sleep disorders using sleep target modulators
11/03/2004EP1471912A1 Method of promoting neuronal growth
11/03/2004EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004EP1471909A1 Pharmaceutical composition and method for treating disorders of the central nervous system
11/03/2004EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004EP1471905A1 Use of cholinesterase antagonists to treat insulin resistance
11/03/2004EP1471904A1 Carnitine in the treatment of geriatric depression
11/03/2004EP1471901A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
11/03/2004EP1471899A1 Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias
11/03/2004EP1471892A2 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
11/03/2004EP1471886A1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use
11/03/2004EP1471871A2 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
11/03/2004EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004EP1404315B1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones
11/03/2004EP1392697B1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f]quinoline
11/03/2004EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004EP1347974B1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
11/03/2004EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004EP1337271B1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
11/03/2004EP1309582B1 Method for the preparation of citalopram
11/03/2004EP1309581B1 Method for the preparation of citalopram
11/03/2004EP1294677B1 Benzophenones and sulfones as inhibitors of glycine uptake
11/03/2004EP1289514B1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
11/03/2004EP1267892B1 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/03/2004EP1261609B1 Triazolotriazinones and the use thereof
11/03/2004EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004EP1131094B1 Multivalent t.d. polio vaccine against at least diphtheria, poliomyelitis and tetanus
11/03/2004EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004EP1102586B1 Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
11/03/2004EP0989850B1 Use of pramipexole in the treatment of restless legs syndrome
11/03/2004EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/03/2004CN1543347A Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine
11/03/2004CN1543346A Novel compounds
11/03/2004CN1543342A Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/03/2004CN1542135A Preparation and use for phospholipase A2 congener from Agkistrodon blomhoffii Ussurensis of Changbai Mountains and genes encoding same
11/03/2004CN1542010A Azolo triazines and pyrimidines
11/03/2004CN1542006A Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine
11/03/2004CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004CN1541705A Lucid ganoderma extract for relieving or neutralizing alcohol effect and its extracting method and uses
11/03/2004CN1541682A Insomnia treating traditional Chinese medicine preparation and its preparing process
11/03/2004CN1541667A Active enzyme biological medicinal composition
11/03/2004CN1541663A Medicine for abstinence of drugs and rehabilitation, and preparing process thereof
11/03/2004CN1541661A Manufacturing technique of acanthopanax root soft capsule
11/03/2004CN1541644A Fluoxetine enteric coated tablet
11/03/2004CN1173992C Hybrid peptide with vascularization inhibiting activity
11/03/2004CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004CN1173972C Azaring-ether derivatives and their use as nicotinic ach receptor modulators
11/03/2004CN1173970C Tetrahydroquinoline derivatives as glycine antagonists
11/03/2004CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004CN1173958C Compound capable of inhibiting thrombocyte agglutination and resisting thrombosis and its preparation and application
11/03/2004CN1173956C Novel piperazinylalkyl thiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of same
11/03/2004CN1173948C Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors
11/03/2004CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/03/2004CN1173928C Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
11/03/2004CN1173926C Substituted 2-phenyl-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system and pharmaceutical compositions containing them
11/03/2004CN1173727C Chinese medicine liquor for clearing and activating main and collateral channels, and its preparation method
11/03/2004CN1173720C Tradtional Chinese prepared medicine for stopping pain and abstaining from drugs
11/03/2004CN1173716C Chinese medicine for nourishing vigor and refreshing brain
11/03/2004CN1173707C Medicinal composition containing baicalin and caffoeoylchinic acid
11/03/2004CN1173701C Orally disintegrating composition containing mirtazapine
11/03/2004CN1173695C Controlled release and odor masking oral pharmaceutical compositions
11/03/2004CN1173694C Pharmaceutical composition for treatment of acute disorders
11/02/2004US6812364 Central nervous system disorders; psychological disorders; anticancer agents
11/02/2004US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004US6812248 Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes
11/02/2004US6812236 Compounds useful in therapy
11/02/2004US6812228 Benzoxazines for use in the treatment of parkinson's disease
11/02/2004US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004US6812225 Pyschological disorders; antidepressants
11/02/2004US6812219 Methods and compositions for treating flaviviruses and pestiviruses
11/02/2004US6812213 Steroidal sapogenins and their derivatives for treating alzheimer's disease
11/02/2004US6812210 Urocortin-III and uses thereof
11/02/2004US6812208 Methods to improve neural outcome
11/02/2004US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004US6811777 Compositions and minimally invasive methods for treating incomplete connective tissue repair
11/02/2004US6811767 Liquid droplet aerosols of nanoparticulate drugs
11/02/2004CA2338704C Oral liquid mucoadhesive compositions
11/02/2004CA2301787C New derivatives of benzo[3,4]cyclobuta[1,2-c]pyrrole, the procedure for preparing them and the pharmaceutical compounds that contain them
11/02/2004CA2296970C Neuropeptide y antagonists
11/02/2004CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors
11/02/2004CA2282279C Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
10/2004
10/28/2004WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004WO2004092186A1 Phosphates of secondary alcohols